| ORIGINAL ARTICLE |
|
| Year : 2023 | Volume
: 2
| Issue : 1 | Page : 4-8 |
|
|
Rheumatic heart disease secondary prophylaxis prescribing patterns and outcomes: A tertiary care hospital experience in Saudi Arabia
Namareq F Aldardeer1, Amnah S Mukhtar1, Bayader S Kalkatawi1, Arwa F Lardhi2, Nezar E Elsheikh3
1 Pharmaceutical Care Department, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia
2 Cardiology Department, Dr. Suliman Fakeeh Hospital, Jeddah, Saudi Arabia
3 Cardiovascular Diseases Department, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia
Correspondence Address:
Namareq F Aldardeer
Pharmaceutical Care Department, King Faisal Specialist Hospital and Research Centre, P.O. Box 40047, Jeddah 21499 MBC J-11
Saudi Arabia
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/sjcp.sjcp_22_22
|
|
|
Background: Rheumatic heart disease (RHD) is a leading cause of heart disease in children and young adults in developing countries and is considered a significant cause of cardiovascular diseases. Antimicrobial prophylaxis is recommended as secondary prevention for heart complications caused by recurrent acute rheumatic fever. Objective: Our study aims to describe the prescribing patterns of RHD antibiotic secondary prophylaxis among eligible patients and highlight the frequency of valvular heart disease complications requiring intervention. Materials and Methods: A single-center retrospective study was conducted at a tertiary hospital in Saudi Arabia. The study included all patients 5 years old and above diagnosed with rheumatic heart fever and/or RHD and eligible for secondary prevention between January 2009 and December 2018. The primary outcome is the frequency of RHD secondary prophylaxis prescribed for eligible patients. Results: Among 806 patients who were screened, 272 patients were eligible for inclusion. A total of 194 (71.3%) were female, and 146 (53.67%) were older than 40. RHD secondary prophylaxis prescribing adherence was found in only 14 of 272 (5.14%). A total of 185 of 272 (68%) patients had at least one cardiac-related intervention during the follow-up period. Valvular heart disease progression was found in 72 of 185 (38.9%) after a primary intervention. Overall mortality was 30 (11%). Conclusion: Our study found low prescribing adherence to RHD secondary prevention among eligible patients in an area with a high disease prevalence. A larger sample size is needed to confirm these findings. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
